UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Leveraging an Implementation– Research Partnership to Improve Effectiveness of Nutrition-Sensitive Programs at the World Food Programme

Food and nutrition bulletin, 2020-03, Vol.41 (1), p.18-37

2020

Volltextzugriff (PDF)

Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2019-04, Vol.321 (13), p.1275

2019

Volltextzugriff (PDF)

Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington's disease gene carriers

Neurobiology of disease, 2015-11, Vol.83, p.115-121

2015

Volltextzugriff (PDF)

Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: A multimodal imaging study

Human brain mapping, 2011-02, Vol.32 (2), p.258-270

2011

Volltextzugriff (PDF)

Microglial activation in presymptomatic Huntington's disease gene carriers

Brain (London, England : 1878), 2007-07, Vol.130 (7), p.1759-1766

2007

Volltextzugriff (PDF)

Safety and serum distribution of anti-SARS-CoV-2 monoclonal antibody MAD0004J08 after intramuscular injection

Nature communications, 2022-04, Vol.13 (1), p.2263-8, Article 2263

2022

Volltextzugriff (PDF)

Monitoring estrogenic activities of waste and surface waters using a novel in vivo zebrafish embryonic (EASZY) assay: Comparison with in vitro cell-based assays and determination of effect-based trigger values

Environment international, 2019-09, Vol.130, p.104896, Article 104896

2019

Volltextzugriff (PDF)

Complications involving the subcutaneous implantable cardioverter-defibrillator: Lessons learned from MAUDE

Heart rhythm, 2020-03, Vol.17 (3), p.447-454

2020

Volltextzugriff (PDF)

Designing stem-cell-based dopamine cell replacement trials for Parkinson’s disease

Nature medicine, 2019-07, Vol.25 (7), p.1045-1053

Barker, Roger A.

2019

Volltextzugriff (PDF)

Hypothalamic involvement in Huntington's disease: an in vivo PET study

Brain (London, England : 1878), 2008-11, Vol.131 (11), p.2860-2869

2008

Volltextzugriff (PDF)

Designing stem-cell-based dopamine cell replacement trials for Parkinson's disease

Nature medicine, 2019-07, Vol.25 (7), p.1045-1053

Barker, Roger A

2019

Volltextzugriff (PDF)

Imaging microglial activation in Huntington's disease

Brain research bulletin, 2007-04, Vol.72 (2), p.148-151

2007

Volltextzugriff (PDF)

Procedure Volume and Outcomes With WATCHMAN Left Atrial Appendage Occlusion

Circulation. Cardiovascular interventions, 2024-06, Vol.17 (6), p.e013466

2024

Volltextzugriff (PDF)

Neuromelanin‐MRI to Quantify and Track Nigral Depigmentation in Parkinson's Disease: A Multicenter Longitudinal Study Using Template‐Based Standardized Analysis

Movement disorders, 2022-05, Vol.37 (5), p.1028-1039

2022

Volltextzugriff (PDF)

Altered PDE10A expression detectable early before symptomatic onset in Huntington's disease

Brain (London, England : 1878), 2015-10, Vol.138 (Pt 10), p.3016

2015

Volltextzugriff (PDF)

Combination Chemotherapy in Advanced Adrenocortical Carcinoma

The New England journal of medicine, 2012-06, Vol.366 (23), p.2189-2197

2012

Volltextzugriff (PDF)

Cortical dopamine dysfunction in symptomatic and premanifest Huntington's disease gene carriers

Neurobiology of disease, 2010-02, Vol.37 (2), p.356-361

2010

Volltextzugriff (PDF)

Long-term Follow-up of Glycemic and Neurological Outcomes in an International Series of Patients With Sulfonylurea-Treated ABCC8 Permanent Neonatal Diabetes

Diabetes care, 2021-01, Vol.44 (1), p.35-42

2021

Volltextzugriff (PDF)

Corrigendum to “Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington's disease gene carriers” [Neurobiol. Dis. 83 (2015) 115–121]

Neurobiology of disease, 2017-02, Vol.98, p.162-162

2017

Volltextzugriff (PDF)

Safety and efficacy of laquinimod for Huntington's disease (LEGATO-HD): a multicentre, randomised, double-blind, placebo-controlled, phase 2 study

Lancet neurology, 2024-03, Vol.23 (3), p.243-255

2024

Volltextzugriff (PDF)

The COVID-19 Pandemic Affects Seasonality, With Increasing Cases of New-Onset Type 1 Diabetes in Children, From the Worldwide SWEET Registry

Diabetes care, 2022-11, Vol.45 (11), p.2594-2601

2022

Volltextzugriff (PDF)

Educators’ Perceptions and Experiences of Online Teacher Professional Development

Journal of Interactive Media in Education, 2024-09, Vol.2024 (1)

2024

Volltextzugriff (PDF)

J05 Legato-hd study: a phase 2 study assessing the efficacy and safety of laquinimod as a treatment for huntington disease

Journal of neurology, neurosurgery and psychiatry, 2018-09, Vol.89 (Suppl 1), p.A99

2018

Volltextzugriff (PDF)

Outcome of cell suspension allografts in a patient with Huntington's disease

Annals of neurology, 2018-12, Vol.84 (6), p.950-956

2018

Volltextzugriff (PDF)

Altered PDE10A expression detectable early before symptomatic onset in Huntington’s disease

Brain (London, England : 1878), 2015-10, Vol.138 (10), p.3016-3029

2015

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(37)
Bücher
(1)

Sprache

Englisch
(38)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Neurology
(5)
Brain
(4)
Neurobiology Of Disease
(3)
Diabetes Care
(2)
Journal Of Neurology, Neurosurgery And Psychiatry
(2)
Nature Medicine
(2)
Annals Of Neurology
(1)
Blood
(1)
Brain Communications
(1)
Brain Research Bulletin
(1)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Leveraging an Implementation– Research Partnership to Improve Effectiveness of Nutrition-Sensitive Programs at the World Food Programme

Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial

Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington's disease gene carriers

Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: A multimodal imaging study

Microglial activation in presymptomatic Huntington's disease gene carriers

Safety and serum distribution of anti-SARS-CoV-2 monoclonal antibody MAD0004J08 after intramuscular injection

Monitoring estrogenic activities of waste and surface waters using a novel in vivo zebrafish embryonic (EASZY) assay: Comparison with in vitro cell-based assays and determination of effect-based trigger values

Complications involving the subcutaneous implantable cardioverter-defibrillator: Lessons learned from MAUDE

Designing stem-cell-based dopamine cell replacement trials for Parkinson’s disease

Hypothalamic involvement in Huntington's disease: an in vivo PET study

Designing stem-cell-based dopamine cell replacement trials for Parkinson's disease

Imaging microglial activation in Huntington's disease

Procedure Volume and Outcomes With WATCHMAN Left Atrial Appendage Occlusion

Neuromelanin‐MRI to Quantify and Track Nigral Depigmentation in Parkinson's Disease: A Multicenter Longitudinal Study Using Template‐Based Standardized Analysis

Altered PDE10A expression detectable early before symptomatic onset in Huntington's disease

Combination Chemotherapy in Advanced Adrenocortical Carcinoma

Cortical dopamine dysfunction in symptomatic and premanifest Huntington's disease gene carriers

Long-term Follow-up of Glycemic and Neurological Outcomes in an International Series of Patients With Sulfonylurea-Treated ABCC8 Permanent Neonatal Diabetes

Corrigendum to “Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington's disease gene carriers” [Neurobiol. Dis. 83 (2015) 115–121]

Safety and efficacy of laquinimod for Huntington's disease (LEGATO-HD): a multicentre, randomised, double-blind, placebo-controlled, phase 2 study

The COVID-19 Pandemic Affects Seasonality, With Increasing Cases of New-Onset Type 1 Diabetes in Children, From the Worldwide SWEET Registry

Educators’ Perceptions and Experiences of Online Teacher Professional Development

J05 Legato-hd study: a phase 2 study assessing the efficacy and safety of laquinimod as a treatment for huntington disease

Outcome of cell suspension allografts in a patient with Huntington's disease

Altered PDE10A expression detectable early before symptomatic onset in Huntington’s disease

Suchergebnisse filtern